Home > Boards > US Listed > Biotechs > Clearside BioMedical, Inc. (CLSD)

someone missed the boat and talking garbage will

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BioSpecialist Member Profile
 
Followed By 121
Posts 2,381
Boards Moderated 1
Alias Born 12/27/07
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 4:56:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2020 4:38:19 PM
Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publica... GlobeNewswire Inc. - 11/16/2020 7:05:00 AM
Clearside Biomedical to Present at the Stifel 2020 Virtual Healthcare Conference GlobeNewswire Inc. - 11/11/2020 7:05:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 5:16:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2020 4:16:31 PM
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/10/2020 4:05:00 PM
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 202... GlobeNewswire Inc. - 10/30/2020 7:05:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2020 4:43:09 PM
Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Di... GlobeNewswire Inc. - 9/23/2020 7:05:10 AM
Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melan... GlobeNewswire Inc. - 9/11/2020 8:30:10 AM
Clearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 4:05:10 PM
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® fo... GlobeNewswire Inc. - 9/9/2020 8:30:10 AM
Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe GlobeNewswire Inc. - 8/26/2020 7:05:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2020 7:54:15 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 8/13/2020 4:29:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/13/2020 4:02:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 4:17:23 PM
Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 8/10/2020 4:05:10 PM
Clearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable su... GlobeNewswire Inc. - 8/10/2020 4:02:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:01:48 PM
Clearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire Inc. - 8/4/2020 7:05:10 AM
Clearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020 GlobeNewswire Inc. - 7/30/2020 7:05:10 AM
Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting GlobeNewswire Inc. - 7/27/2020 7:05:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/26/2020 5:11:29 PM
BioSpecialist   Saturday, 02/16/19 10:19:56 AM
Re: ResearchDD post# 66
Post # of 183 
someone missed the boat and talking garbage will not change that muahahaha

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences